Skip to main content

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Celiac Disease and NIH Women's Health Research

Signs, Symptoms, and Risk Factors

Celiac disease is a chronic autoimmune condition that occurs in approximately 1% of the U.S. population, and its incidence has been increasing over the past few decades. In people with celiac disease, an immune-mediated response in the small intestine is driven by ingesting dietary gluten, a protein found in wheat, barley, rye, and spelt. This response can damage the intestinal tract via intraepithelial lymphocytosis and villous atrophy, which can lead to malabsorption of essential nutrients. In some cases, poor absorption of micronutrients can cause complications such as anemia, neuropathies, osteopenia, or osteoporosis. Other clinical signs and symptoms of celiac disease include diarrhea, abdominal discomfort, and weight loss.1 - 4 Celiac disease has also been associated with certain psychiatric disorders, including anxiety, depression, eating disorders, and attention-deficit/hyperactivity disorder (ADHD), although these associations are not well understood.5 , 6

This condition has a strong genetic component; those who have a parent, sibling, or child with celiac disease have a 10% to 15% higher risk of developing it themselves. People with the human leukocyte antigen (HLA)-DQ2 or HLA-DQ8 haplotypes are predisposed to developing an autoimmune response to gluten, although a substantial number of non-HLA genes have also been linked to this condition.2 - 4 , 7 People with certain chromosomal disorders (e.g., Down syndrome) or other autoimmune disorders (e.g., type 1 diabetes) also have a higher risk of celiac disease.1 - 3 While gluten is the essential environmental driver, other environmental factors (e.g., those that affect the gut microbiome) are likely involved in the development of this condition.3

Impact on Women's Health

Women are about twice as likely to receive a diagnosis of celiac disease as men.3 , 8 , 9 The presenting symptoms of celiac disease seem to be similar between women and men, although one study reported that constipation was more commonly observed in women.8 The same study also noted that women were more likely than men to have low levels of ferritin at the time of diagnosis.

When left untreated, the nutritional deficits caused by celiac disease can delay the onset of menarche in girls.10 , 11 Some research has also noted a potential association between undiagnosed or untreated celiac disease and female infertility and adverse pregnancy outcomes;10 in one systematic review and meta-analysis, the risk of having celiac disease was found to be three times higher among women who were experiencing infertility than among controls.12 Most of the available data suggest that these risks are not higher in women with well-treated celiac disease.

Diagnosis and Treatment

A physical exam can identify some of the signs and symptoms of celiac disease, such as signs of malnutrition, oral ulcers, and dermatitis herpetiformis. Diagnosis generally involves confirming that the patient has elevated levels of the serologic antibody tissue transglutaminase immunoglobulin A (tTG-IgA) and performing esophagogastroduodenoscopy to obtain duodenal biopsies.2 , 4 , 13

Strict adherence to a gluten-free diet can help mitigate the symptoms of celiac disease and prevent damage to the intestines and long-term complications. However, maintaining this diet over the long term can be difficult, and people with this condition often require dietitian support to avoid micronutrient deficiencies. Persistent villous atrophy has been observed in a significant proportion of people with celiac disease even after 2 years of following a gluten-free diet,2 , 14 and some people with celiac disease have persistent symptoms despite maintaining this diet. These individuals may have comorbid conditions (e.g., inflammatory bowel syndrome), continued gluten exposure, or refractory celiac disease.2 , 15

Ongoing Research

Because celiac disease can present with a variety of signs and symptoms, diagnosis is often delayed,16 with some studies reporting that the average time between the appearance of symptoms and diagnosis can be as long as 10 years.17 , 18 In addition, women are more likely to have a longer time to diagnosis for celiac disease than men.19 , 20 Current research is investigating the potential of new diagnostic strategies for celiac disease, including the use of blood-based assays that can detect gluten‐specific T cells in vitro.21

Questions also remain about the potential impacts of celiac disease on menopause and pregnancy.

NIH Research Highlight

Researchers supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are working to understand the underlying mechanisms of tissue destruction and repair in people with celiac disease. The Tissue Destruction and Healing in Celiac Disease clinical trial, which began in 2023, involves a series of gluten challenge and de-challenge studies. The information collected from this trial will clarify how interactions between genetics, microbiota, and the immune system cause the different clinical presentations of celiac disease and affect the severity of tissue damage. The aim of the trial is to develop better resources for managing celiac disease.22

The Gluten Technology and Education for Celiac Health (GLUTECH) trial, another NIDDK-supported study, is a large-scale clinical trial that is testing the effectiveness of using gluten-detection technologies to manage celiac disease. The researchers are investigating whether combining these technologies with telehealth strategies can improve clinical outcomes among patients who recently received a celiac disease diagnosis. The goal is to provide an accessible option for the long-term monitoring of celiac disease and to reduce both the physical and psychological burdens of this condition.23

  1. Definition & facts for celiac disease. National Institute of Diabetes and Digestive and Kidney Diseases. Updated October 2020. Accessed August 13, 2026. https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/definition-facts
  2. Blom JJ, Gidrewicz D, Turner J, Duerksen DR, Pinto-Sanchez MI. Diagnosis and management of celiac disease. CMAJ. 2025;197(38):E1258-E1265. doi:10.1503/cmaj.230091. https://pmc.ncbi.nlm.nih.gov/articles/PMC12594544/
  3. Caio G, Volta U, Sapone A, et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17(1):142. doi:10.1186/s12916-019-1380-z. https://pmc.ncbi.nlm.nih.gov/articles/PMC6647104/
  4. Daley SF, Haseeb M. Celiac Disease. StatPearls Publishing; 2025. Updated February 4, 2025. Accessed August 13, 2026. https://www.ncbi.nlm.nih.gov/books/NBK441900/
  5. Alkhiari R. Psychiatric and neurological manifestations of celiac disease in adults. Cureus. 2023;15(3):e35712. doi:10.7759/cureus.35712. https://pmc.ncbi.nlm.nih.gov/articles/PMC9984242/
  6. Clappison E, Hadjivassiliou M, Zis P. Psychiatric manifestations of coeliac disease, a systematic review and meta-analysis. Nutrients. 2020;12(1)doi:10.3390/nu12010142. https://pmc.ncbi.nlm.nih.gov/articles/PMC7019223/
  7. Sharma A, Liu X, Hadley D, et al. Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort. PLoS One. 2016;11(3):e0152476. doi:10.1371/journal.pone.0152476. https://pmc.ncbi.nlm.nih.gov/articles/PMC4807782/
  8. Jansson-Knodell CL, King KS, Larson JJ, Van Dyke CT, Murray JA, Rubio-Tapia A. Gender-based differences in a population-based cohort with celiac disease: more alike than unalike. Dig Dis Sci. 2018;63(1):184-192. doi:10.1007/s10620-017-4835-0. https://pmc.ncbi.nlm.nih.gov/articles/PMC5961510/
  9. Tarar ZI, Zafar MU, Farooq U, Basar O, Tahan V, Daglilar E. The progression of celiac disease, diagnostic modalities, and treatment options. J Investig Med High Impact Case Rep. 2021;9:23247096211053702. doi:10.1177/23247096211053702. https://pmc.ncbi.nlm.nih.gov/articles/PMC8767653/
  10. Freeman HJ. Reproductive changes associated with celiac disease. World J Gastroenterol. 2010;16(46):5810-4. doi:10.3748/wjg.v16.i46.5810. https://pmc.ncbi.nlm.nih.gov/articles/PMC3001971/
  11. Costa STB, Sanmarful IS. Primary amenorrhoea as a manifestation of coeliac disease. BMJ Case Rep. 2021;14(1)doi:10.1136/bcr-2020-239260. https://pmc.ncbi.nlm.nih.gov/articles/PMC7843338/
  12. Castano M, Gomez-Gordo R, Cuevas D, Nunez C. Systematic review and meta-analysis of prevalence of coeliac disease in women with infertility. Nutrients. 2019;11(8)doi:10.3390/nu11081950. https://pmc.ncbi.nlm.nih.gov/articles/PMC6723639/
  13. Celiac disease tests. National Institute of Diabetes and Digestive and Kidney Diseases. Updated February 2021. Accessed August 13, 2026. https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/digestive-diseases/celiac-disease-health-care-professionals
  14. Fernandez-Banares F, Beltran B, Salas A, et al. Persistent villous atrophy in de novo adult patients with celiac disease and strict control of gluten-free diet adherence: a multicenter prospective study (CADER Study). Am J Gastroenterol. 2021;116(5):1036-1043. doi:10.14309/ajg.0000000000001139. https://pubmed.ncbi.nlm.nih.gov/33491958/
  15. Treatment for celiac disease. National Institute of Diabetes and Digestive and Kidney Diseases. Updated October 2020. Accessed August 13, 2026. https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/treatment
  16. Zylberberg HM, Miller EBP, Reidy D, et al. Delay in celiac disease diagnosis among patients with high-risk screening conditions: results from a United States claims database. J Clin Med. 2025;14(18)doi:10.3390/jcm14186471. https://pmc.ncbi.nlm.nih.gov/articles/PMC12470924/
  17. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96(1):126-31. doi:10.1111/j.1572-0241.2001.03462.x. https://pubmed.ncbi.nlm.nih.gov/11197241/
  18. Norstrom F, Lindholm L, Sandstrom O, Nordyke K, Ivarsson A. Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011;11:118. doi:10.1186/1471-230X-11-118. https://pmc.ncbi.nlm.nih.gov/articles/PMC3233515/
  19. Vavricka SR, Vadasz N, Stotz M, et al. Celiac disease diagnosis still significantly delayed - doctor's but not patients' delay responsive for the increased total delay in women. Dig Liver Dis. 2016;48(10):1148-54. doi:10.1016/j.dld.2016.06.016. https://pubmed.ncbi.nlm.nih.gov/27401607/
  20. Fuchs V, Kurppa K, Huhtala H, Collin P, Maki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49(11):1304-10. doi:10.3109/00365521.2014.923502. https://pubmed.ncbi.nlm.nih.gov/25139307/
  21. Moscatelli OG, Russell AK, Henneken LM, Hardy MY, Tye-Din JA. An optimised whole blood interleukin-2 release assay is more sensitive than interferon-gamma ELISpot for detecting and quantifying gluten-specific CD4(+) T-cell responses in coeliac disease. Clin Transl Immunology. 2025;14(12):e70063. doi:10.1002/cti2.70063. https://pmc.ncbi.nlm.nih.gov/articles/PMC12695692/
  22. RePORTER project details: tissue destruction and healing in celiac disease. National Institutes of Health. Accessed August 13, 2026. https://reporter.nih.gov/project-details/11159754
  23. RePORTER project details: evaluation of novel technologies to improve clinical management of celiac disease: the GLUTECH trial. National Institutes of Health. Accessed August 13, 2026. https://reporter.nih.gov/project-details/10924061

Learn More About NIH Resources for Celiac Disease Research





Last updated: 09/04/2026